Company Analysis Sequent Scientific Limited
1. Summary
Advantages
- The stock's return over the last year (39.07%) is higher than the sector average (-42.81%).
Disadvantages
- Price (170.8 βΉ) is higher than fair price (14.49 βΉ)
- Dividends (0%) are below the sector average (0.6496%).
- Current debt level 29.3% has increased over 5 years from 20.32%.
- The company's current efficiency (ROE=-5.46%) is lower than the sector average (ROE=3.69%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Sequent Scientific Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -9% | -6.2% | -0.6% |
| 90 days | -8.6% | -5.6% | -4.8% |
| 1 year | 39.1% | -42.8% | 7.2% |
SEQUENT vs Sector: Sequent Scientific Limited has outperformed the "Healthcare" sector by 81.88% over the past year.
SEQUENT vs Market: Sequent Scientific Limited has outperformed the market by 31.85% over the past year.
Stable price: SEQUENT is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SEQUENT with weekly volatility of 0.7513% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (170.8 βΉ) is higher than the fair price (14.49 βΉ).
Price is higher than fair: The current price (170.8 βΉ) is 91.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (56.11).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (43.66).
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.13) is lower than that of the sector as a whole (8.08).
P/BV vs Market: The company's P/BV (4.13) is lower than that of the market as a whole (6.15).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.15) is lower than that of the sector as a whole (17.79).
P/S vs Market: The company's P/S indicator (2.15) is lower than that of the market as a whole (8.67).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-53.42) is lower than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (-53.42) is lower than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -27.52% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-27.52%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (-5.46%) is lower than that of the sector as a whole (3.69%).
ROE vs Market: The company's ROE (-5.46%) is lower than that of the market as a whole (-0.3088%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.33%) is lower than that of the sector as a whole (3.44%).
ROA vs Market: The company's ROA (-2.33%) is lower than that of the market as a whole (7.53%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (11.26%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.6496%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
